Back to results
US 2023/0265392 A1Published application
Enhanced systems for cell-mediated oncolytic viral therapy
AssigneeCalidi Biotherapeutics, Inc.
InventorsAntonio FERNANDEZ SANTIDRIAN, Duong Hoang NAUYEN, Dobrin DRAGANOV
Life of this patent
Estimating the term…
Abstract
Provided herein are enhanced systems for potentiating cell-mediated oncolytic viral therapy. Also provided are modified viruses for such systems, and methods of treatment of cancers by administering such systems.
Claims42
A cell-assisted viral expression system (CAVES), comprising a carrier cell and an oncolytic virus, wherein:
- the carrier cell comprising the oncolytic virus was produced by infection of the cell with virus at a low MOI, followed by incubation for sufficient time under conditions in which proteins encoded by the virus are expressed, whereby:
- the carrier cell expresses at least one immunomodulatory protein or recombinant therapeutic protein encoded by the virus by virtue of association of the virus with the carrier cell, but by virtue of the low MOI the virus does not lyse the cell;
- and
- the carrier cell is not a tumor cell.
1 more element
Dependencies are inferred from the claim text.